1. Home > Latest Topics >

Mortality/morbidity associated with HAP/ VAP

20 June, 2018

Mortality morbidity associated with HAPVAP


LATEST TOPICS

Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024
Managing severe infections: Practical approaches for antibiotic use, including combination therapy
05 March, 2024
Updating Traditional Approaches: Expert Insights on Addressing Urinary Tract Infections
26 February, 2024
Antibiotic resistance may be driven by diverse factors, including extreme climatic events
14 February, 2024

RELATED ARTICLES

Fluoroquinolones in the management of hospital-acquired pneumonia
20 June, 2023
Gram-negative pneumonia: combination therapy and the role of quinolones
06 July, 2022
Levofloxacin in the Treatment of Hospital-Acquired Pneumonia: Insights into Antibiotic Resistance and Tolerance
18 October, 2023
Observing the Development of Quinolones from the Rational Application of Antibacterial Drugs During the COVID-19 Pandemic
21 March, 2023
Highly antimicrobial-resistant bacteria increase severity and mortality in patients with intensive care unit-acquired pneumonia
16 September, 2021